|
128 |
Thomasson RR, Yazer MH, Gorham JD, Dunbar NM, MTP Use Study Investigators on behalf of the BEST Collaborative. |
International assessment of massive transfusion protocol contents and indications for activation. |
Transfusion. 2019 May;59(5)1637-1643. Epub 2019 Feb 5. |
|
|
127 |
Kaufman RM, Dinh A, Cohn CS, Fung MK, Gorlin J, Melanson S, Murphy MF, Ziman A, Elahie AL, Chasse D, Degree L, Dunbar NM, Dzik WH, Flanagan P, Gabert K, Ipe TS, Jackson B, Lane D, Raspollini E, Ray C, Sharon Y, Ellis M, Selleng K, Staves J, Yu P, Zeller M, Yazer M; BEST Collaborative. |
Electronic patient identification for sample labeling reduces wrong blood in tube errors. |
Transfusion. 2019 Mar;59(3):972-980. |
|
|
126 |
Harm SK, Yazer MH, Bub CB, Cohn CS, Jacob EK, Kutner JM, Mair DC, Raval JS, Shaz BH, Ziman A, Dunbar NM, on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. |
Seasonal variability is not observed in the rates of high anti-A and anti-B titers in plasma, apheresis platelet, and whole blood units tested by different methods. |
Transfusion. 2019 Feb;59(2):762-767. Epub 2018 Dec 11. |
|
|
125 |
Pagano MB, Dunbar NM, Tinmouth A, Apelseth TO, Lozano M, Cohn CS, Stanworth SJ; Biomedical Excellence for Safer Transfusion (BEST) Collaborative. |
A methodological review of the quality of reporting of surveys in transfusion medicine. |
Transfusion. 2018 Nov;58(11):2720-2727. Epub 2018 Sep 27. |
|
|
124 |
Takanashi M, Selogie E, Reems JA, Stroncek D, Fontaine MJ, Girdlestone J, Garritsen HSP, Young P, McKenna DH, Szczepiorkowski ZM; Biomedical Excellence for Safer Transfusion (BEST) Collaborative. |
Current practices for viability testing of cryopreserved cord blood products: an international survey by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. |
Transfusion. 2018 Sep;58(9):2184-2191. |
|
|
123 |
Dunbar NM, Yazer MH, OPTIMUS Study Investigators on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. |
inventory management, and utilization during shortage: the OPTIMUS study. |
Transfusion. 2018 Jun;58(6):1348-1355. Epub 2018 Feb 25. |
|
|
122 |
de Korte D, Thibault L, Handke W, Harm SK, Morrison A, Fitzpatrick A, Marks DC, Yi QL, Acker JP; Biomedical Excellence for Safer Transfusion (BEST) collaborative. |
Timing of gamma irradiation and blood donor sex influences in vitro characteristics of red blood cells. |
Transfusion. 2018 Apr;58(4):917-926. Epub 2018 Jan 17. |
|
|
121 |
Yazer MH, Dunbar NM, Cohn C, Dillon J, Eldib H, Jackson B, Kaufman R, Murphy MF, O'Brien K, Raval JS, Seheult J, Staves J, Waters JH on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. |
Blood product transfusion and wastage rates in obstetric haemorrhage. |
Transfusion 2018 June;58(6):1408-1413. Epub 2018 Mar 7. |
|
|
120 |
Yazer MH, Anani WQ, Denomme GA, Karafin MS, Sayers M, Shaz BH on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. |
Trends in antigen-negative red blood cell distributions by racial or ethnic groups in the United States. |
Transfusion 2018; 58: 145–150. |
|
|
119 |
Seheult JN, Shaz B, Bravo M, Croxon H, Devine D, Doncaster C, Field S, Flanagan P, Germain M, Gregoire Y, Karafin M, Kelting N, Lewis M, O’Brien C, Murphy MF, Rossmann S, Sayers M, Shinar E, Takanashi M, Titelstad K, Yazer MH on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. |
Changes in plasma unit distributions to hospitals over a 10 year period. |
Transfusion. 2018 Apr;58(4):1012-1020. |
|
